New therapies are needed for alcohol abuse, a major public health problem in the U.S. and worldwide. There are only three FDA-approved drugs for treatment of alcohol abuse (naltrexone, acamprosate and disulfuram). On average these drugs yield only moderate success in reducing long-term alcohol consumption. Electroacupuncture has been shown to alleviate various drugs of abuse, including alcohol. Although previous studies have shown that electroacupuncture reduced alcohol consumption, the underlying mechanisms have not been fully elucidated. ΔFosB and FosB are members of the Fos family of transcription factors implicated in neural plasticity in drug addiction; a connection between electroacupuncture's treatment of alcohol abuse and the Fos family has not been established. In this study, we trained rats to drink large quantities of ethanol in a modified intermittent access two-bottle choice drinking procedure. When rats achieved a stable baseline of ethanol consumption, electroacupuncture (100 Hz or 2 Hz, 30 min each day) was administered at Zusanli (ST36) for 6 consecutive days. The level of FosB/ΔFosB in reward-related brain regions was assessed by immunohistochemistry. We found that the intake of and preference for ethanol in rats under 100 Hz, but not 2 Hz electroacupuncture regiment were sharply reduced. The reduction was maintained for at least 72 hours after the termination of electroacupuncture treatment. Conversely, 100 Hz electroacupuncture did not alter the intake of and preference for the natural rewarding agent sucrose. Additionally, FosB/ΔFosB levels in the prefrontal cortex, striatal region and the posterior region of ventral tegmental area were increased following excessive ethanol consumption, but were reduced after six-day 100 Hz electroacupuncture. Thus, this study demonstrates that six-day 100 Hz electroacupuncture treatment effectively reduces ethanol consumption and preference in rats that chronically drink excessive amount of ethanol. This effect of electroacupuncture may be mediated by down-regulation of FosB/ΔFosB in reward-related brain regions.
References
[1]
Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, et al. (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295: 2003–2017.
[2]
Mann K, Lehert P, Morgan MY (2004) The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol Clin Exp Res 28: 51–63.
[3]
Meyers RJ, Smith JE, Lash DN (2003) The Community Reinforcement Approach. Recent Dev Alcohol 16: 183–195.
[4]
Lu GW (1983) Characteristics of afferent fiber innervation on acupuncture points zusanli. Am J Physiol 245: R606–612.
[5]
Stux G (1987) Acupuncture text book and atlas. Berlin: Springer-Verlag.
[6]
Jindal V, Ge A, Mansky PJ (2008) Safety and efficacy of acupuncture in children: a review of the evidence. J Pediatr Hematol Oncol 30: 431–442.
[7]
Han J, Cui C, Wu L (2011) Acupuncture-related techniques for the treatment of opiate addiction: a case of translational medicine. Front Med 5: 141–150.
[8]
Yoshimoto K, Kato B, Sakai K, Shibata M, Yano, et al (2001) Electroacupuncture stimulation suppresses the increase in alcohol-drinking behavior in restricted rats. Alcohol Clin Exp Res 25: 63S–68S.
[9]
Karst M, Passie T, Friedrich S, Wiese B, Schneider U (2002) Acupuncture in the treatment of alcohol withdrawal symptoms: a randomized, placebo-controlled inpatient study. Addict Biol 7: 415–419.
[10]
Kim YH, Schiff E, Waalen J, Hovell M (2005) Efficacy of acupuncture for treating cocaine addiction: a review paper. J Addict Dis 24: 115–132.
[11]
Kunz S, Schulz M, Lewitzky M, Driessen M, Rau H (2007) Ear acupuncture for alcohol withdrawal in comparison with aromatherapy: a randomized-controlled trial. Alcohol Clin Exp Res 31: 436–442.
[12]
Overstreet DH, Cui CL, Ma YY, Guo CY, Han JS, et al. (2008) Electroacupuncture reduces voluntary alcohol intake in alcohol-preferring rats via an opiate-sensitive mechanism. Neurochem Res 33: 2166–2170.
[13]
Yang CH, Lee BB, Jung HS, Shim I, Roh PU, et al. (2002) Effect of electroacupuncture on response to immobilization stress. Pharmacol Biochem Behav 72: 847–855.
[14]
Li J, Zou Y, Ye JH (2011) Low frequency electroacupuncture selectively decreases voluntarily ethanol intake in rats. Brain Res Bull 86: 428–434.
[15]
Robison AJ, Nestler EJ (2011) Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12: 623–637.
[16]
Perrotti LI, Weaver RR, Robison B, Renthal W, Maze I, et al. (2008) Distinct patterns of DeltaFosB induction in brain by drugs of abuse. Synapse 62: 358–369.
[17]
Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, et al. (2001) Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410: 376–380.
[18]
Zachariou V, Bolanos CA, Selley DE, Theobald D, Cassidy MP, et al. (2006) An essential role for DeltaFosB in the nucleus accumbens in morphine action. Nat Neurosci 9: 205–211.
[19]
Li J, Cheng Y, Bian WL, Liu X, Zhang C, et al. (2010) Region-specific induction of FosB/deltaFosB by voluntary alcohol intkae: effects of naltrexone. Alcohol Clin Exp Res 34.
[20]
Cui CL, Wu LZ, Luo F (2008) Acupuncture for the treatment of drug addiction. Neurochem Res 33: 2013–2022.
[21]
Yang CH, Yoon SS, Hansen DM, Wilcox JD, Blumell BR, et al. (2010) Acupuncture inhibits GABA neuron activity in the ventral tegmental area and reduces ethanol self-administration. Alcohol Clin Exp Res 34: 2137–2146.
[22]
Yoon SS, Yang EJ, Lee BH, Jang EY, Kim HY, et al. (2012) Effects of acupuncture on stress-induced relapse to cocaine-seeking in rats. Psychopharmacology. (Berl).
[23]
Perrotti LI, Bolanos CA, Choi KH, Russo SJ, Edwards S, et al. (2005) DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment. Eur J Neurosci 21: 2817–2824.
[24]
Simms JA, Steensland P, Medina B, Abernathy KE, Chandler LJ, et al. (2008) Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats. Alcohol Clin Exp Res 32: 1816–1823.
[25]
Li J, Bian W, Dave V, Ye JH (2011) Blockade of GABA(A) receptors in the paraventricular nucleus of the hypothalamus attenuates voluntary ethanol intake and activates the hypothalamic-pituitary-adrenocortical axis. Addict Biol(16): 600–614.
[26]
Li J, Nie H, Bian W, Dave V, Janak PH, et al. (2012) Microinjection of Glycine into the Ventral Tegmental Area Selectively Decreases Ethanol Consumption. J Pharmacol Exp Ther(341): 196–204.
[27]
Poklis A, Mackell MA (1982) Evaluation of a modified alcohol dehydrogenase assay for the determination of ethanol in blood. Clin Chem 28: 2125–2127.
[28]
Nielsen CK, Simms JA, Pierson HB, Li R, Saini SK, et al. (2008) A novel delta opioid receptor antagonist, SoRI-9409, produces a selective and long-lasting decrease in ethanol consumption in heavy-drinking rats. Biol Psychiatry 64: 974–981.
[29]
Zhao RJ, Yoon SS, Lee BH, Kwon YK, Kim KJ, et al. (2006) Acupuncture normalizes the release of accumbal dopamine during the withdrawal period and after the ethanol challenge in chronic ethanol-treated rats. Neurosci Lett 395: 28–32.
[30]
Paxinos G, Watson C (2007) The Rat brain in stereotaxic coordinates 6th edition, Academic press.
[31]
Wang GB, Wu LZ, Yu P, Li YJ, Ping XJ, et al. (2011) Multiple 100 Hz electroacupuncture treatments produced cumulative effect on the suppression of morphine withdrawal syndrome: Central preprodynorphin mRNA and p-CREB implicated. Peptides 32: 713–721.
[32]
Nestler EJ (2005) Is there a common molecular pathway for addiction? Nat Neurosci 8: 1445–1449.
[33]
Chen G, Cuzon Carlson VC, Wang J, Beck A, Heinz A, et al. (2011) Striatal involvement in human alcoholism and alcohol consumption, and withdrawal in animal models. Alcohol Clin Exp Res 35: 1739–1748.
[34]
Kaufling J, Veinante P, Pawlowski SA, Freund-Mercier MJ, Barrot M (2009) Afferents to the GABAergic tail of the ventral tegmental area in the rat. J Comp Neurol 513: 597–621.
[35]
Shi XD, Wang GB, Ma YY, Ren W, Luo F, et al. (2004) Repeated peripheral electrical stimulations suppress both morphine-induced CPP and reinstatement of extinguished CPP in rats: accelerated expression of PPE and PPD mRNA in NAc implicated. Brain Res Mol Brain Res 130: 124–133.
[36]
Wu LZ, Cui CL, Tian JB, Ji D, Han JS (1999) Suppression of morphine withdrawal by electroacupuncture in rats: dynorphin and kappa-opioid receptor implicated. Brain Res 851: 290–296.
[37]
Wee S, Koob GF (2010) The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology (Berl) 210: 121–135.
[38]
Fadda P, Tronci S, Colombo G, Fratta W (1999) Differences in the opioid system in selected brain regions of alcohol-preferring and alcohol-nonpreferring rats. Alcohol Clin Exp Res 23: 1296–1305.
[39]
Marinelli PW, Kiianmaa K, Gianoulakis C (2000) Opioid propeptide mRNA content and receptor density in the brains of AA and ANA rats. Life Sci 66: 1915–1927.
[40]
Winkler A, Spanagel R (1998) Differences in the kappa opioid receptor mRNA content in distinct brain regions of two inbred mice strains. Neuroreport 9: 1459–1464.
[41]
Lindholm S, Werme M, Brene S, Franck J (2001) The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat. Behav Brain Res 120: 137–146.
[42]
Mitchell JM, Liang MT, Fields HL (2005) A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats. Psychopharmacology (Berl) 182: 384–392.
[43]
Xuei X, Dick D, Flury-Wetherill L, Tian HJ, Agrawal A, et al. (2006) Association of the kappa-opioid system with alcohol dependence. Mol Psychiatry 11: 1016–1024.
[44]
Han JS (2003) Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies. Trends Neurosci 26: 17–22.
[45]
Logrip ML, Janak PH, Ron D (2008) Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake. FASEB J 22: 2393–2404.
[46]
Logrip ML, Janak PH, Ron D (2009) Blockade of ethanol reward by the kappa opioid receptor agonist U50,488H. Alcohol 43: 359–365.
[47]
Everitt BJ, Robbins TW (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8: 1481–1489.
[48]
Vanderschuren LJ, Di Ciano P, Everitt BJ (2005) Involvement of the dorsal striatum in cue-controlled cocaine seeking. J Neurosci 25: 8665–8670.
[49]
Voorn P, Vanderschuren LJ, Groenewegen HJ, Robbins TW, Pennartz CM (2004) Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci 27: 468–474.
[50]
Jeanblanc J, He DY, Carnicella S, Kharazia V, Janak PH, et al. (2009) Endogenous BDNF in the dorsolateral striatum gates alcohol drinking. J Neurosci 29: 13494–13502.
[51]
Krawczyk DC (2002) Contributions of the prefrontal cortex to the neural basis of human decision making. Neurosci Biobehav Rev 26: 631–664.
[52]
Nestler EJ (2008) Review. Transcriptional mechanisms of addiction: role of DeltaFosB. Philos Trans R Soc Lond B Biol Sci 363: 3245–3255.
[53]
Winstanley CA, LaPlant Q, Theobald DE, Green TA, Bachtell RK, et al. (2007) DeltaFosB induction in orbitofrontal cortex mediates tolerance to cocaine-induced cognitive dysfunction. J Neurosci 27: 10497–10507.
[54]
Winstanley CA, Green TA, Theobald DE, Renthal W, LaPlant Q, et al. (2009) DeltaFosB induction in orbitofrontal cortex potentiates locomotor sensitization despite attenuating the cognitive dysfunction caused by cocaine. Pharmacol Biochem Behav 93: 278–284.
[55]
Kaufling J, Waltisperger E, Bourdy R, Valera A, Veinante P, et al. (2010) Pharmacological recruitment of the GABAergic tail of the ventral tegmental area by acute drug exposure. Br J Pharmacol 161: 1677–1691.
[56]
Ford CP, Beckstead MJ, Williams JT (2007) Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents. J Neurophysiol 97: 883–891.
[57]
Margolis EB, Lock H, Chefer VI, Shippenberg TS, Hjelmstad GO, et al. (2006) Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc Natl Acad Sci U S A 103: 2938–2942.
